The new strain, also known as XBB.1.16, is presenting a few new issues that we haven't really seen with infections before.
It’s labeled by the World Health Organisation as a “variant under monitoring,” according toAdvertisement
As of last week, it represented a little more than 7% of cases in the U.S. nationwide — though certain parts of the country are being hit with this variant harder than others. The symptoms of this new variant are also a little different from what we’ve seen in the past. How can you spot them and how can you protect yourself? Here’s what to know:Particularly in children, conjunctivitis — red, itchy eyes — has been a reported symptom, according to Binnicker.
“Depending on where you live, if you’re in the United States, if you’re in a place that’s starting to see the pollination come out, a lot of these symptoms are really similar to what you would see with spring allergies,” Guest said. “And so that does bring up the need to make sure you’re doing COVID tests if you have any of these symptoms.”Red, itchy eyes have been reported in children infected with XBB.1.16, but adults may experience the symptom as well.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
What to Know About New COVID-19 Variant ArcturusXBB.1.16—which a group of scientists on Twitter nicknamed “Arcturus”—is one of more than 600 Omicron subvariants that are currently circulating
Weiterlesen »
Fast-spreading Covid Arcturus may have unique symptom not seen in other strainsDoctors have reported spotting a symptom that has not been seen in previous variants and sub-variants of coronavirus.
Weiterlesen »
New Arcturus Covid strain is most contagious so far but UK cases are fallingThe “Arcturus” subvariant is thought to be the most contagious strain since the start of the pandemic 🦠 But scientists believe that immunity from previous infections, as well as improving weather, have prevented it from taking hold
Weiterlesen »
Arcturus Covid variant has unique new symptom, research suggestsThe strain has been found in a total of 29 countries
Weiterlesen »
First person dies with Arcturus Covid variant as global cases riseAn elderly man in Thailand who is yet unnamed is the first reported death from the Omicron subvariant.
Weiterlesen »
Previous BCG vaccination is associated with less severe clinical progression of COVID-19 - BMC MedicineBackground BCG vaccination, originally used to prevent tuberculosis, is known to “train” the immune system to improve defence against viral respiratory infections. We investigated whether a previous BCG vaccination is associated with less severe clinical progression of COVID-19 Methods A case-control study comparing the proportion with a BCG vaccine scar (indicating previous vaccination) in cases and controls presenting with COVID-19 to health units in Brazil. Cases were subjects with severe COVID-19 (O2 saturation | 90%, severe respiratory effort, severe pneumonia, severe acute respiratory syndrome, sepsis, and septic shock). Controls had COVID-19 not meeting the definition of “severe” above. Unconditional regression was used to estimate vaccine protection against clinical progression to severe disease, with strict control for age, comorbidity, sex, educational level, race/colour, and municipality. Internal matching and conditional regression were used for sensitivity analysis. Results BCG was associated with high protection against COVID-19 clinical progression, over 87% (95% CI 74–93%) in subjects aged 60 or less and 35% (95% CI − 44–71%) in older subjects. Conclusions This protection may be relevant for public health in settings where COVID-19 vaccine coverage is still low and may have implications for research to identify vaccine candidates for COVID-19 that are broadly protective against mortality from future variants. Further research into the immunomodulatory effects of BCG may inform COVID-19 therapeutic research.
Weiterlesen »